Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term colorectal cancer. Found 35 abstracts

no pagination
Dmitrieva-Posocco O, Dzutsev A, Posocco DF, Hou V, Yuan W, Thovarai V, Mufazalov IA, Gunzer M, Shilovskiy IP, Khaitov MR, Trinchieri G, Waisman A, Grivennikov SI. Cell-Type-Specific Responses to Interleukin-1 Control Microbial Invasion and Tumor-Elicited Inflammation in Colorectal Cancer. Immunity. 2019 Jan 15;50(1):166-180e7.   PMCID: PMC6490968
El-Deiry WS, Winer A, Slifker M, Taylor S, Adamson BJ, Meropol NJ, Ross EA. Disease Control With FOLFIRI Plus Ziv-aflibercept (zFOLFIRI) Beyond FOLFIRI Plus Bevacizumab: Case Series in Metastatic Colorectal Cancer (mCRC). Frontiers in oncology. 2019 Jan;9:142.   PMCID: PMC6426764
Leystra AA, Clapper ML. Gut Microbiota Influences Experimental Outcomes in Mouse Models of Colorectal Cancer. Genes (Basel). 2019 Nov 07;10(11).   PMCID: PMC6895921
Rogers HL, Dumenci L, Epstein RM, Siminoff LA. Impact of Patient Gender and Race and Physician Communication on Colorectal Cancer Diagnostic Visits in Primary Care. Journal of women's health (2002). 2019 May;28(5):612-20.   PMCID: PMC6537478
Witherspoon M, Sandu D, Lu C, Wang K, Edwards R, Yeung A, Gelincik O, Manfredi G, Gross S, Kopelovich L, Lipkin S. ETHE1 overexpression promotes SIRT1 and PGC1alpha mediated aerobic glycolysis, oxidative phosphorylation, mitochondrial biogenesis and colorectal cancer. Oncotarget. 2019 Jun 18;10(40):4004-17.   PMCID: PMC6592291
Gray PN, Tsai P, Chen D, Wu S, Hoo J, Mu W, Li B, Vuong H, Lu HM, Batth N, Willett S, Uyeda L, Shah S, Gau CL, Umali M, Espenschied C, Janicek M, Brown S, Margileth D, Dobrea L, Wagman L, Rana H, Hall MJ, Ross T, Terdiman J, Cullinane C, Ries S, Totten E, Elliott AM. TumorNext-Lynch-MMR: A comprehensive next generation sequencing assay for the detection of germline and somatic mutations in genes associated with mismatch repair deficiency and Lynch syndrome. Oncotarget. 2018 Apr 17;9(29):20304-22.   PMCID: PMC5945525
Kupfer SS, Lubner S, Coronel E, Pickhardt PJ, Tipping M, Graffy P, Keenan E, Ross E, Li T, Weinberg DS. Adherence to postresection colorectal cancer surveillance at National Cancer Institute-designated Comprehensive Cancer Centers. Cancer medicine. 2018 Nov;7(11):5351-8.   PMCID: PMC6247039
Meropol NJ, Feng Y, Grem JL, Mulcahy MF, Catalano PJ, Kauh JS, Hall MJ, Saltzman JN, George TJ, Zangmeister J, Chiorean EG, Cheema PS, O'Dwyer PJ, Benson AB. Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG-ACRIN Cancer Research Group (E4203). Cancer. 2018 Feb 15;124(4):688-97.   PMCID: PMC6226304
Patel RS, Wen KY, Aggarwal R. Demographic Pattern and Hospitalization Outcomes of Depression among 2.1 Million Americans with Four Major Cancers in the United States. Medical sciences (Basel, Switzerland). 2018 Oct 24;6(4).   PMCID: PMC6313571
Piccoli M, D'Angelo E, Crotti S, Sensi F, Urbani L, Maghin E, Burns A, De Coppi P, Fassan M, Rugge M, Rizzolio F, Giordano A, Pilati P, Mammano E, Pucciarelli S, Agostini M. Decellularized colorectal cancer matrix as bioactive microenvironment for in vitro 3D cancer research. Journal of cellular physiology. 2018 Aug;233(8):5937-48.
Deihimi S, Lev A, Slifker M, Shagisultanova E, Xu Q, Jung K, Vijayvergia N, Ross EA, Xiu J, Swensen J, Gatalica Z, Andrake M, Dunbrack RL, El-Deiry WS. BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations. Oncotarget. 2017 Jun 20;8(25):39945-62.   PMCID: PMC5522275
Reese JB, Lepore SJ, Handorf EA, Haythornthwaite JA. Emotional approach coping and depressive symptoms in colorectal cancer patients: The role of the intimate relationship. Journal of psychosocial oncology. 2017 Sep;35(5):578-96.   PMCID: PMC5804335
Xu J, Cortellino S, Tricarico R, Chang WC, Scher G, Devarajan K, Slifker M, Moore R, Bassi MR, Caretti E, Clapper M, Cooper H, Bellacosa A. Thymine DNA Glycosylase (TDG) is involved in the pathogenesis of intestinal tumors with reduced APC expression. Oncotarget. 2017 Oct 27;8(52):89988-97.   PMCID: PMC5685726
Cheng D, Zhao S, Tang H, Zhang D, Sun H, Yu F, Jiang W, Yue B, Wang J, Zhang M, Yu Y, Liu X, Sun X, Zhou Z, Qin X, Zhang X, Yan D, Wen Y, Peng Z. MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4. Oncotarget. 2016 Jul 19;7(29):45199-213.   PMCID: PMC5216716
Overman MJ, Morris V, Moinova H, Manyam G, Ensor J, Lee MS, Eng C, Kee B, Fogelman D, Shroff RT, LaFramboise T, Mazard T, Feng T, Hamilton S, Broom B, Lutterbaugh J, Issa JP, Markowitz SD, Kopetz S. Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin. Oncotarget. 2016 Oct 11;7(41):67495-506.   PMCID: PMC5341892
El-Deiry WS, Vijayvergia N, Xiu J, Scicchitano A, Lim B, Yee NS, Harvey HA, Gatalica Z, Reddy S. Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites. Cancer Biol Ther. 2015 Jan;16(12):1726-37.   PMCID: PMC4847814
Thomson MD, Siminoff LA. Finding medical care for colorectal cancer symptoms: experiences among those facing financial barriers. Health education & behavior : the official publication of the Society for Public Health Education. 2015 Feb;42(1):46-54.   PMCID: PMC4604569
Tricarico R, Cortellino S, Riccio A, Jagmohan-Changur S, Van der Klift H, Wijnen J, Turner D, Ventura A, Rovella V, Percesepe A, Lucci-Cordisco E, Radice P, Bertario L, Pedroni M, Ponz de Leon M, Mancuso P, Devarajan K, Cai KQ, Klein-Szanto AJ, Neri G, Moller P, Viel A, Genuardi M, Fodde R, Bellacosa A. Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis. Oncotarget. 2015 Oct 16;6(40):42892-904.   PMCID: PMC4767479
Hall MJ, Ruth K, Giri VN. Rates and predictors of colorectal cancer screening by race among motivated men participating in a prostate cancer risk assessment program. Cancer. 2012 Jan;118(2):478-84.   PMCID: PMC3195866
Mejia A, Schulz S, Hyslop T, Weinberg DS, Waldman SA. Molecular staging individualizing cancer management. Journal of surgical oncology. 2012 Apr;105(5):468-74.   PMCID: PMC3312802
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term colorectal cancer

colorectal cancer Adult Male Middle Aged Aged Female Colorectal Neoplasms pathology metastasis prostate cancer Neoplasm Metastasis oxaliplatin Apc Neoplasm Staging irinotecan microbiota genetics Tumor Biomarkers drug therapy tumor microenvironment Inbred BALB C Mice Mice insurance 2000 lmann a-expert opin pharmaco-v1-p737 guanylyl cyclase-c microsatellite instability coping mCRC Genetics Virginia Tumor Cell Line methylation surveillance mutations Tp53 Ercc1 peritoneal cancer long-term survival Brca2 veterans transcriptase-polymerase chain reaction African American Organoplatinum Compounds surrogate end-points prognostic markers cell type specific signaling adverse effects Community Health Centers prognosis extracellular matrix Epithelial-Mesenchymal Transition Down-Regulation united-states primary health care cancer High-Throughput Nucleotide Sequencing guanylyl cyclase C resected MicroRNAs oncology mismatch repair deficiency Interviews as Topic predictive factors surgical adjuvant Cimp Mbd4 3' Untranslated Regions Lung Neoplasms metabolism med1 5-fluorouracil mismatch repair Mutation Mlh1 thymidylate synthase predictive markers emotional approach Socioeconomic Factors Narration DNA Methylation epidemiology Gene Amplification Tdg tumor elicited inflammation patterns Gene Expression Profiling care seeking colorectal-carcinoma blood next generation sequencing prognostic factors and AE are all employees of Ambry Genetics MJ is a paid consultant for Ambry Cytokine Cox2 azacitidine Kras mortality aerobic glycolysis Type II DNA Topoisomerases Health Services Accessibility Immunohistochemistry quantitative reverse Capecitabine Interleukin 1 Delayed Diagnosis women Proportional Hazards Models lung cancer c-MET Smad4 Protein breast cancer inpatient psychiatry screening survivorship therapy intestinal cancer disease control 3D in vitro culture Vimentin relationship quality Insurance Coverage drug effects mouse models zFOLFIRI Lynch syndrome barriers to care Her2 statistics & numerical data metastatic disease precision medicine Ntrk Smad4 molecular profiling Neoplasm Drug Resistance familial adenomatous polyposis Medical Records lymph nodes antitumor immunity mammography CpG Islands lymph-node evaluation bevacizumab vimentin Health Insurance breast Antineoplastic Combined Chemotherapy Protocols staging ii colon-cancer Folfiri intimacy
Last updated on Friday, January 03, 2020